Hexagon Capital Partners’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,000
| Closed | -$1.08K | – | 1361 |
|
|
2025
Q1 | $1.08K | Hold |
4,000
| – | – | ﹤0.01% | 1534 |
|
|
2024
Q4 | $2.08K | Hold |
4,000
| – | – | ﹤0.01% | 1407 |
|
|
2024
Q3 | $13K | Hold |
4,000
| – | – | ﹤0.01% | 841 |
|
|
2024
Q2 | $12K | Hold |
4,000
| – | – | ﹤0.01% | 820 |
|
|
2024
Q1 | $18.6K | Hold |
4,000
| – | – | ﹤0.01% | 696 |
|
|
2023
Q4 | $16.6K | Hold |
4,000
| – | – | ﹤0.01% | 702 |
|
|
2023
Q3 | $12K | Hold |
4,000
| – | – | ﹤0.01% | 695 |
|
|
2023
Q2 | $9.84K | Buy |
4,000
+2,400
| +150% | +$5.9K | ﹤0.01% | 753 |
|
|
2023
Q1 | $3.62K | Hold |
1,600
| – | – | ﹤0.01% | 948 |
|
|
2022
Q4 | $5.58K | Hold |
1,600
| – | – | ﹤0.01% | 888 |
|
|
2022
Q3 | $59K | Hold |
1,600
| – | – | 0.02% | 343 |
|
|
2022
Q2 | $30K | Hold |
1,600
| – | – | 0.01% | 454 |
|
|
2022
Q1 | $43K | Hold |
1,600
| – | – | 0.01% | 393 |
|
|
2021
Q4 | $36K | Hold |
1,600
| – | – | 0.01% | 402 |
|
|
2021
Q3 | $42K | Hold |
1,600
| – | – | 0.01% | 365 |
|
|
2021
Q2 | $51K | Hold |
1,600
| – | – | 0.01% | 319 |
|
|
2021
Q1 | $56K | Hold |
1,600
| – | – | 0.02% | 293 |
|
|
2020
Q4 | $51K | Hold |
1,600
| – | – | 0.02% | 266 |
|
|
2020
Q3 | $47K | Buy |
+1,600
| New | +$47K | 0.02% | 262 |
|